Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 343, Issue 2, 2012, Pages 389-400

  Kwilasz, Andrew J ^a   Negus, S Stevens ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR; DRONABINOL; KETOPROFEN; LACTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ANTINOCICEPTION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TOLERANCE; INTRACRANIAL SELF STIMULATION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SATIETY; SEDATION; SELF STIMULATION;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHAVIOR, ANIMAL; BRAIN; CANNABINOID RECEPTOR AGONISTS; CONDITIONING, OPERANT; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ELECTRODES, IMPLANTED; KETOPROFEN; LACTIC ACID; MALE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; SELF STIMULATION; TETRAHYDROCANNABINOL;

EID: 84867605835     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.197780     Document Type: Article

References (60)

1. 9-tetrahydrocannabinol administration. J Pharmacol Exp Ther 303:340-346.
2. Beaulieu P (2006) Effects of nabilone, a synthetic cannabinoid, on postoperative pain. Can J Anaesth 53:769-775.
3. Blackburn-Munro G (2004) Pain-like behaviours in animals-how human are they? Trends Pharmacol Sci 25:299-305.
4. Booker L, Naidu PS, Razdan RK, Mahadevan A, and Lichtman AH (2009) Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception. Drug Alcohol Depend 105:42-47.
5. Borsook D and Becerra L (2011) CNS animal fMRI in pain and analgesia. Neurosci Biobehav Rev 35:1125-1143.
6. 9- tetrahydrocannabinol in postoperative pain. Pain 106:169-172.
7. Campbell FA, Tramèr MR, Carroll D, Reynolds DJ, Moore RA, and McQuay HJ (2001) Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 323:13-16. (Pubitemid 32681998)
8. Carlezon WA Jr and Chartoff EH (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987-2995.
9. Cheng Y and Hitchcock SA (2007) Targeting cannabinoid agonists for inflammatory and neuropathic pain. Expert Opin Investig Drugs 16:951-965. (Pubitemid 47074154)
10. Cleeland CS and Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 23:129-138.
11. Cobos EJ, Ghasemlou N, Araldi D, Segal D, Duong K, and Woolf CJ (2012) Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia. Pain 153:876-884.
12. De Vry J, Jentzsch KR, Kuhl E, and Eckel G (2004) Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development. Behav Pharmacol 15:1-12. (Pubitemid 38241508)
13. Do Carmo GP, Folk JE, Rice KC, Chartoff E, Carlezon WA Jr, and Negus SS (2009) The selective non-peptidic Δ opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats. Eur J Pharmacol 604:58-65.
14. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, et al. (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113:9-19. (Pubitemid 40038441)
15. Elikkottil J, Elikottil J, Gupta P, and Gupta K (2009) The analgesic potential of cannabinoids. J Opioid Manag 5:341-357.
16. Farrimond JA, Mercier MS, Whalley BJ, and Williams CM (2011) Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation. Phytother Res 25:170-188.
17. Finn DP, Beckett SR, Roe CH, Madjd A, Fone KC, Kendall DA, Marsden CA, and Chapman V (2004) Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain. Eur J Neurosci 19:678-686. (Pubitemid 38241307)
18. Flecknell P (2009) Laboratory Animal Anaesthesia, Academic Press/Elsevier, London.
19. Fox A, Kesingland A, Gentry C, McNair K, Patel S, Urban L, and James I (2001) The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 92:91-100.
20. 9-tetrahydrocannabinol. Psychopharmacology 96:142-144.
21. Greenwald MK and Stitzer ML (2000) Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. Drug Alcohol Depend 59:261-275. (Pubitemid 30254241)
22. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
23. 9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats. Behav Pharmacol 16:373-380.
24. Karst M, Wippermann S, and Ahrens J (2010) Role of cannabinoids in the treatment of pain and (painful) spasticity. Drugs 70:2409-2438.
25. Khodayar MJ, Shafaghi B, Naderi N, and Zarrindast MR (2006) Antinociceptive effect of spinally administered cannabinergic and 2-adrenoceptor drugs on the formalin test in rat: possible interactions. J Psychopharmacol 20:67-74.
26. 9-tetrahydrocannabinol does not affect visceral sensitivity to rectal distension in healthy volunteers and IBS patients. Neurogastroenterol Motil 23:30-35, e2.
27. Kraft B (2012) Is there any clinically relevant cannabinoid-induced analgesia? Pharmacology 89:237-246.
28. Kraft B, Frickey NA, Kaufmann RM, Reif M, Frey R, Gustorff B, and Kress HG (2008) Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers. Anesthesiology 109:101-110.
29. Lichtman AH and Martin BR (1991) Spinal and supraspinal components of cannabinoid- induced antinociception. J Pharmacol Exp Ther 258:517-523.
30. Martin TJ, Kim SA, Buechler NL, Porreca F, and Eisenach JC (2007) Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics. Anesthesiology 106:312-322. (Pubitemid 46185177)
31. Matson DJ, Broom DC, Carson SR, Baldassari J, Kehne J, and Cortright DN (2007) Inflammation-induced reduction of spontaneous activity by adjuvant: a novel model to study the effect of analgesics in rats. J Pharmacol Exp Ther 320:194-201. (Pubitemid 46025734)
32. Miller CC, Murray TF, Freeman KG, and Edwards GL (2004) Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain. Physiol Behav 80:611-616. (Pubitemid 38230958)
33. Miller LL, Picker MJ, Schmidt KT, and Dykstra LA (2011) Effects of morphine on pain-elicited and pain-suppressed behavior in CB1 knockout and wildtype mice. Psychopharmacology 215:455-465.
34. Mogil JS (2009) Animal models of pain: progress and challenges. Nat Rev Neurosci 10:283-294.
35. 9-tetrahydrocannabinol in mice. PLoS Biol 5:e269.
36. 9- tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions. Pain 105:79-88.
37. National Research Council (2003) Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research, National Academies Press, Washington, DC.
38. Negus SS, Bilsky EJ, Do Carmo GP, and Stevenson GW (2010a) Rationale and methods for assessment of pain-depressed behavior in preclinical assays of pain and analgesia. Methods Mol Biol 617:79-91.
39. Negus SS, Morrissey EM, Rosenberg M, Cheng K, and Rice KC (2010b) Effects of κ opioids in an assay of pain-depressed intracranial self-stimulation in rats. Psychopharmacology (Berl) 210:149-159.
40. Negus SS, O'Connell R, Morrissey E, Cheng K, and Rice KC (2012a) Effects of peripherally restricted opioid receptor agonists on pain-related stimulation and depression of behavior in rats. J Pharmacol Exp Ther 340:501-509.
41. Negus SS, Rosenberg MB, Altarifi AA, O'Connell RH, Folk JE, and Rice KC (2012b) Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats. J Pain 13:317-327.
42. Negus SS, Vanderah TW, Brandt MR, Bilsky EJ, Becerra L, and Borsook D (2006) Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J Pharmacol Exp Ther 319:507-514.
43. Panagis G, Vlachou S, and Nomikos GG (2008) Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependenceproducing properties. Curr Drug Abuse Rev 1:350-374.
44. Pereira Do Carmo G, Stevenson GW, Carlezon WA, and Negus SS (2009) Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior. Pain 144:170-177.
45. Price DD (2002) Central neural mechanisms that interrelate sensory and affective dimensions of pain. Mol Interv 2:392-403, 339.
46. Raft D, Gregg J, Ghia J, and Harris L (1977) Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response. Clin Pharmacol Ther 21:26-33. (Pubitemid 8024156)
47. Rice A ed (2006) Wall and Melzack's Textbook of Pain, Churchill Livingstone, Philadelphia, PA.
48. Sain NM, Liang A, Kane SA, and Urban MO (2009) Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain. Neuropharmacology 57:235-241.
49. Sarzi-Puttini P, Atzeni F, Lanata L, Bagnasco M, Colombo M, Fischer F, and D'Imporzano M (2010) Pain and ketoprofen: what is its role in clinical practice? Reumatismo 62:172-188.
50. Sofia RD, Vassar HB, and Knobloch LC (1975) Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats. Psychopharmacologia 40:285-295.
51. Stevenson GW, Bilsky EJ, and Negus SS (2006) Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. J Pain 7:408-416. (Pubitemid 43794888)
52. Stevenson GW, Cormier J, Mercer H, Adams C, Dunbar C, Negus SS, and Bilsky EJ (2009) Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. Life Sci 85:309-315.
53. Vlachou S, Nomikos GG, and Panagis G (2005) CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat. Psychopharmacology 179:498-508. (Pubitemid 40569051)
54. 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents. Behav Pharmacol 18:311-319.
55. Wallace M, Schulteis G, Atkinson JH, Wolfson T, Lazzaretto D, Bentley H, Gouaux B, and Abramson I (2007) Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology 107:785-796. (Pubitemid 351325971)
56. Whiteside GT, Adedoyin A, and Leventhal L (2008) Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology 54:767-775.
57. 9-tetrahydrocannabinol in adolescent and adult rats. J Pharmacol Exp Ther 320:1097-1105.
58. 9-THC. Physiol Behav 65:343-346.
59. Willis WD Jr (2009) The role of TRPV1 receptors in pain evoked by noxious thermal and chemical stimuli. Exp Brain Res 196:5-11.
60. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.